April 4, 2024 Myths v. Facts: Can Bayh-Dole March-In Rights Lower Drug Costs?, 4/4/2024 Backgrounders, Issue Briefs, and White Papers
February 13, 2024 What Universities Are Saying About the Biden Administration’s Draft Framework for March-In Rights, 2/13/2024 Backgrounders, Issue Briefs, and White Papers
August 25, 2023 What They Are Saying About America’s Technology-Transfer System, 8/25/2023 Backgrounders, Issue Briefs, and White Papers / Resources
February 8, 2023 Issue Brief: March-in Rights, 2/8/2023 Backgrounders, Issue Briefs, and White Papers / Resources
January 13, 2023 Issue Brief: IP, Innovation, and American Universities, 1/12/2023 Backgrounders, Issue Briefs, and White Papers / Resources
March 2, 2022 What Tech Transfer Experts Are Saying About March-In Rights, 3/2/2022 Backgrounders, Issue Briefs, and White Papers / Resources
January 28, 2022 The Legacy of Bayh-Dole’s Success on U.S. Global Competitiveness Today, 1/12/2022 Backgrounders, Issue Briefs, and White Papers / Resources
April 13, 2021 “What They Are Saying” About NIST’s Proposed Bayh-Dole Rule Change, 4/13/2021 Backgrounders, Issue Briefs, and White Papers / Resources
February 9, 2021 White Paper: To Foster Innovation, Biden Administration Must Protect Bayh-Dole, 2/9/2021 Backgrounders, Issue Briefs, and White Papers / Resources
April 23, 2020 Bayh-Dole & Biopharmaceutical Innovation: Myths vs. Facts, Bayh-Dole Coalition, 4/23/2020 Backgrounders, Issue Briefs, and White Papers / Resources
